Combining ultrasound-guided treatments for jumper's knee
Effect of Adding Ultrasound-guided Percutaneous Neuromodulation to Conventional Treatment of Ultrasound-guided Percutaneous Electrolysis and Eccentric Exercises in Patients With Patellar Tendinopathy. Randomized Clinical Trial
This study is testing a new combination of ultrasound-guided treatments and exercises to see if it can help athletes aged 18 to 50 with jumper's knee feel better when other treatments haven't worked.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 26 (estimated) |
| Ages | 18 Years to 50 Years |
| Sex | All |
| Sponsor | Universidad de Zaragoza Academic / other |
| Locations | 1 site (Zaragoza) |
| Trial ID | NCT06685302 on ClinicalTrials.gov |
What this trial studies
This clinical trial investigates the effects of combining ultrasound-guided percutaneous neuromodulation, percutaneous electrolysis, and eccentric exercises on patients with patellar tendinopathy, commonly known as jumper's knee. The study focuses on athletes aged 18 to 50 who experience localized knee pain and have not responded to conventional treatments. Participants will undergo these innovative non-surgical interventions to assess improvements in pain and function. The trial aims to provide a comprehensive approach to treating this prevalent condition among athletes.
Who should consider this trial
Good fit: Ideal candidates are males aged 18 to 50 who engage in sports at least three times a week and have experienced knee pain for at least two weeks.
Not a fit: Patients with contraindications for invasive techniques or severe chronic conditions affecting the knee may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly reduce pain and improve function for patients suffering from jumper's knee.
How similar studies have performed: While there is limited research on the combination of these specific treatments, similar approaches have shown promise in managing patellar tendinopathy.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Aged between 18 and 50 years * Experiencing localized anterior knee pain at the lower pole of the patella for at least two weeks * Engaging in any type of sport at least three times per week * Scoring less than 80 points on the VISA-P questionnaire in its Spanish version * Having carefully read and signed the study's informed consent form Exclusion Criteria: * Any contraindication for invasive techniques (such as belonephobia, allergies to materials used, cancer, thrombophlebitis, skin conditions, or febrile states) * Any lower limb pathology or severe chronic condition (e.g., Osgood-Schlatter syndrome or Sinding-Larsen-Johansson syndrome) * Pharmacological treatment within the 48 hours prior to the intervention * Knee surgeries within the past year * Corticosteroid injections within the previous 3 months
Where this trial is running
Zaragoza
- University of Zaragoza — Zaragoza, Spain (Recruiting)
Study contacts
- Study coordinator: Alberto Carcasona, Physiotherapist
- Email: acarcasona@unizar.es
- Phone: 666387648
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.